Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor
go back to main search page
Accession:CHEBI:76835 term browser browse the term
Definition:An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).
Synonyms:related_synonym: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+)acceptor) inhibitors;   EC 1.1.1.* inhibitor;   EC 1.1.1.* inhibitors


show annotations for term's descendants           Sort by:
 


Your selection has 4128 annotated objects. The maximum number of objects that can be shown is 2000. The list is too large to display.

  • Select a more specific term using the term browser
  • Download the entire list for this term
  • Display annotations for this term only (exclude descendants)



  • Term paths to the root
    Path 1
    Term Annotations click to browse term
      CHEBI ontology 19821
        role 19769
          biological role 19769
            biochemical role 19389
              enzyme inhibitor 18398
                EC 1.* (oxidoreductase) inhibitor 16722
                  EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor 5831
                    EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor 4128
                      EC 1.1.1.1 (alcohol dehydrogenase) inhibitor + 28
                      EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor + 210
                      EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor + 1226
                      EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor + 34
                      EC 1.1.1.159 (7alpha-hydroxysteroid dehydrogenase) inhibitor + 0
                      EC 1.1.1.170 [3beta-hydroxysteroid-4alpha-carboxylate 3-dehydrogenase (decarboxylating)] inhibitor + 0
                      EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor + 257
                      EC 1.1.1.188 (prostaglandin-F synthase) inhibitor + 650
                      EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor + 591
                      EC 1.1.1.205 (IMP dehydrogenase) inhibitor + 935
                      EC 1.1.1.21 (aldehyde reductase) inhibitor + 1184
                      EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor + 10
                      EC 1.1.1.25 (shikimate dehydrogenase) inhibitor + 2033
                      EC 1.1.1.267 (1-deoxy-D-xylulose-5-phosphate reductoisomerase) inhibitor + 0
                      EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor + 992
                      EC 1.1.1.37 (malate dehydrogenase) inhibitor + 0
                      EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor + 0
                      EC 1.1.1.44 (NADP(+)-dependent decarboxylating phosphogluconate dehydrogenase) inhibitor + 14
    paths to the root